Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Press

Showing results (161-170 of 273) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancerA Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2025
Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With an FDA-Approved BenchmarkSunil Badve, Jason S White, Francisco Sapunar, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Annals of Surgical Oncology|March 8, 2022
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
British Journal of Cancer|December 18, 2008
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancerG E Konecny, L Santos, B Winterhoff, et al.
Breast Cancer Research and Treatment|August 4, 2022
Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History StudyUgonna Ihenacho, Ann S Hamilton, Wendy J Mack, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?Huiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Cancer Research|January 14, 2010
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences studyHuiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Pageof 28

Showing results (161-170 of 273) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancerA Reles, W H Wen, A Schmider, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 26, 2013
Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trialM A Gordon, H M Gundacker, J Benedetti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Serum Human Epidermal Growth Factor 2 Extracellular Domain as a Predictive Biomarker for Lapatinib Treatment Efficacy in Patients With Advanced Breast CancerChee Khoon Lee, Lucy Davies, Val J Gebski, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2025
Analytical Comparison of Commonly Used Laboratory-Developed Tests for the Assessment of Ki-67 in Breast Carcinoma With an FDA-Approved BenchmarkSunil Badve, Jason S White, Francisco Sapunar, et al.
Annals of Surgical Oncology|January 9, 2022
Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
Annals of Surgical Oncology|March 8, 2022
Correction to: Circulating Tumor Cell Transcriptomics as Biopsy Surrogates in Metastatic Breast CancerAlexander Ring, Daniel Campo, Tania B Porras, et al.
British Journal of Cancer|December 18, 2008
HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancerG E Konecny, L Santos, B Winterhoff, et al.
Breast Cancer Research and Treatment|August 4, 2022
Lifetime personal cigarette smoking and risk of young-onset breast cancer by subtype among non-Hispanic Black and White women in the Young Women's Health History StudyUgonna Ihenacho, Ann S Hamilton, Wendy J Mack, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2009
Breast cancer receptor status: do results from a centralized pathology laboratory agree with SEER registry reports?Huiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Cancer Research|January 14, 2010
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences studyHuiyan Ma, Yaping Wang, Jane Sullivan-Halley, et al.
Pageof 28